<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
                        <id>https://faqsir.com/company/docmorris-ag/feed</id>
                                <link href="https://faqsir.com/company/docmorris-ag/feed" rel="self"></link>
            <link rel="hub" href="https://pubsubhubbub.appspot.com/" />
                                <title><![CDATA[DocMorris AG — Announcements]]></title>
                    
                                <subtitle>DocMorris AG (SIX:DOCM) announcements published on FAQSIR. AI-generated content. Paid-for issuer communication. Not investment advice. Published in partnership with DocMorris AG. DocMorris AG pays FAQSIR a subscription fee for this page.</subtitle>
                                                    <updated>2026-10-14T10:37:33+00:00</updated>
                        <entry>
            <title><![CDATA[DocMorris announces CHF 96.8 million New Bonds due 2031 and CHF 13.83 conversion price]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-announces-chf-968-million-new-bonds-due-2031-and-chf-1383-conversion-price" />
            <id>https://faqsir.com/3306</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris has set the issue size and initial conversion price for its New Bonds due 2031, while outlining the repurchase and cancellation of its Convertible Bonds 2028. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:39+00:00</published>
            <updated>2026-10-14T10:35:39+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris completes private placement of convertible bonds due 2031]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-completes-private-placement-of-convertible-bonds-due-2031" />
            <id>https://faqsir.com/3311</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris Finance B.V. has completed a private placement of approximately CHF 100 million in convertible bonds due 2031, guaranteed by DocMorris AG. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:54+00:00</published>
            <updated>2026-10-14T10:35:54+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris launches approx. CHF 100 million bond placement to repurchase 2028 convertibles]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-launches-approx-chf-100-million-bond-placement-to-repurchase-2028-convertibles" />
            <id>https://faqsir.com/3304</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris is launching new Convertible Bonds due 2031 to help finance the privately negotiated repurchase of its outstanding CHF 49.6 million Convertible Bonds due in August 2028. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:33+00:00</published>
            <updated>2026-10-14T10:35:33+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris raises 2026 guidance after first-half Rx and Digital Services growth]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-raises-2026-guidance-after-first-half-rx-and-digital-services-growth" />
            <id>https://faqsir.com/3308</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported stronger first-half performance in its prescription medicines and Digital Services businesses, prompting higher 2026 guidance. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:49+00:00</published>
            <updated>2026-10-14T10:35:49+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports 15.2 per cent external revenue growth in Q2 2026]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-152-per-cent-external-revenue-growth-in-q2-2026" />
            <id>https://faqsir.com/3310</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported higher second-quarter and first-half revenue in 2026, led by prescription medicines and Digital Services. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:52+00:00</published>
            <updated>2026-10-14T10:35:52+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris announces AI-driven efficiency programme with 100 FTE reduction]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-announces-ai-driven-efficiency-programme-with-100-fte-reduction" />
            <id>https://faqsir.com/3302</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris is accelerating its AI-First strategy with workflow automation, a reduction of around 100 full-time equivalents and recurring annual savings targeted at at least CHF 15 million. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:30+00:00</published>
            <updated>2026-10-14T10:35:30+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris shareholders reject CEPD board challenge at 2026 AGM]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-shareholders-reject-cepd-board-challenge-at-2026-agm" />
            <id>https://faqsir.com/3309</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris AG shareholders supported the Board of Directors’ recommendations at the company’s 2026 Annual General Meeting in Zurich, while rejecting proposals from minority shareholder CEPD N.V. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:49+00:00</published>
            <updated>2026-10-14T10:35:49+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris publishes AGM invitation amid board election dispute]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-publishes-agm-invitation-amid-board-election-dispute" />
            <id>https://faqsir.com/3319</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris will hold its Annual General Meeting in Zurich on 12 May 2026, with competing board proposals at the centre of the agenda. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:28+00:00</published>
            <updated>2026-10-14T10:36:28+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports Q1 2026 growth and confirms EBITDA break-even expectation]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-q1-2026-growth-and-confirms-ebitda-break-even-expectation" />
            <id>https://faqsir.com/3320</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported higher revenue across its business areas in the first quarter of 2026, while adjusted EBITDA improved by CHF 9.8 million year-on-year. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:45+00:00</published>
            <updated>2026-10-14T10:36:45+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris and Hello Inside announce metabolic health integration]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-and-hello-inside-announce-metabolic-health-integration" />
            <id>https://faqsir.com/3301</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris and Hello Inside have announced an integration bringing metabolic health checks and personalised programmes to the DocMorris app’s new Care section. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:26+00:00</published>
            <updated>2026-10-14T10:35:26+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris announces Google partnership for AI-first digital health platform]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-announces-google-partnership-for-ai-first-digital-health-platform" />
            <id>https://faqsir.com/3317</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris plans to use Google’s AI models, software and cloud infrastructure as part of a planned transformation of its digital health platform. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:20+00:00</published>
            <updated>2026-10-14T10:36:20+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports 2025 targets met as Google partnership and logistics changes advance]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-2025-targets-met-as-google-partnership-and-logistics-changes-advance" />
            <id>https://faqsir.com/3314</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported growth across its business units in 2025, alongside an AI-focused partnership with Google and plans to consolidate logistics in Heerlen. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:17+00:00</published>
            <updated>2026-10-14T10:36:17+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris proposes three Board candidates ahead of 12 May AGM]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-proposes-three-board-candidates-ahead-of-12-may-agm" />
            <id>https://faqsir.com/3312</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris AG is planning changes to its Board of Directors, with three current members due to step down at the end of the Annual General Meeting on 12 May 2026. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:55+00:00</published>
            <updated>2026-10-14T10:35:55+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris receives TÜV Rheinland certification extension for refrigerated medicine deliveries]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-receives-tuv-rheinland-certification-extension-for-refrigerated-medicine-deliveries" />
            <id>https://faqsir.com/3300</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[The certification extension follows an audit of DocMorris’ documentation, logistics operations and delivery process for refrigerated medicines. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:18+00:00</published>
            <updated>2026-10-14T10:35:18+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris and Infermedica plan AI symptom-checking integration]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-and-infermedica-plan-ai-symptom-checking-integration" />
            <id>https://faqsir.com/3305</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris is cooperating with Infermedica to integrate a medically certified AI symptom checker into its digital health services. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:35+00:00</published>
            <updated>2026-10-14T10:35:35+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris Finance B.V. Announces Early Redemption of 6.875% Convertible Bonds Due 2026]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-finance-bv-announces-early-redemption-of-6875-convertible-bonds-due-2026" />
            <id>https://faqsir.com/3307</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris Finance B.V. has exercised its option to redeem its 6.875% Convertible Bonds due 15 September 2026. Bonds that are not converted will be redeemed at nominal value plus accrued interest for 80 days. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:46+00:00</published>
            <updated>2026-10-14T10:35:46+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris agrees to repurchase around CHF 14.4 million of 2026 convertible bonds]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-agrees-to-repurchase-around-chf-144-million-of-2026-convertible-bonds" />
            <id>https://faqsir.com/3299</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[The proposed purchase is expected to settle in the coming days and would reduce DocMorris’s outstanding 2026 convertible bonds to less than CHF 8.0 million after cancellation. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:34:35+00:00</published>
            <updated>2026-10-14T10:34:35+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports 11.1 per cent external revenue growth in 2025]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-111-per-cent-external-revenue-growth-in-2025" />
            <id>https://faqsir.com/3313</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported 11.1 per cent growth in external revenue for 2025, while fourth-quarter external revenue increased by 15.5 per cent. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:06+00:00</published>
            <updated>2026-10-14T10:36:06+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports results of tender offer for 2026 convertible bonds]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-results-of-tender-offer-for-2026-convertible-bonds" />
            <id>https://faqsir.com/3303</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris has accepted all 72,713 convertible bonds tendered under its offer, with 22,259 Bonds expected to remain outstanding after settlement. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:35:31+00:00</published>
            <updated>2026-10-14T10:35:31+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris Starts Tender Offer Period for Outstanding Convertible Bonds Due 2026]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-starts-tender-offer-period-for-outstanding-convertible-bonds-due-2026" />
            <id>https://faqsir.com/3316</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris has announced the start of the tender offer period for its Outstanding Convertible Bonds due 2026 following the end of the cooling-off period. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:19+00:00</published>
            <updated>2026-10-14T10:36:19+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris completes CHF 49.6 million convertible bond placement]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-completes-chf-496-million-convertible-bond-placement" />
            <id>https://faqsir.com/3318</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris Finance B.V. has completed the placement of CHF 49.6 million in senior unsecured convertible bonds due 2028. The company also announced terms for a separate planned tender offer covering its outstanding 2026 convertible bonds. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:27+00:00</published>
            <updated>2026-10-14T10:36:27+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris launches approx. CHF 45 million convertible bond offering to fund proposed 2026 bond buyback]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-launches-approx-chf-45-million-convertible-bond-offering-to-fund-proposed-2026-bond-buyback" />
            <id>https://faqsir.com/3321</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris Finance B.V. is launching approx. CHF 45 million of senior unsecured convertible bonds due 2028, with proceeds intended to support an envisaged early buyback of the company’s 2026 convertible bonds. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:37:33+00:00</published>
            <updated>2026-10-14T10:37:33+00:00</updated>
        </entry>
            <entry>
            <title><![CDATA[DocMorris reports higher nine-month revenue as Rx growth accelerates]]></title>
            <link rel="alternate" href="https://faqsir.com/company/docmorris-ag/docmorris-reports-higher-nine-month-revenue-as-rx-growth-accelerates" />
            <id>https://faqsir.com/3315</id>
            <author>
                <name><![CDATA[FAQSIR News Desk]]></name>
                    </author>
            <summary type="html">
                <![CDATA[DocMorris reported higher revenue for the first nine months, accelerating sequential Rx growth, gains across its non-Rx business and changes to its AI and commercial leadership. AI-generated content. Paid-for issuer communication. Not investment advice.]]>
            </summary>
                                                <category term="News" />
                        
            <category scheme="http://cv.iptc.org/newscodes/digitalsourcetype/" term="trainedAlgorithmicMedia" label="AI-generated content" />
            <rights type="text">AI-generated content. Paid-for issuer communication. Not investment advice.</rights>

            <published>2026-10-14T10:36:18+00:00</published>
            <updated>2026-10-14T10:36:18+00:00</updated>
        </entry>
    </feed>
